Meningococcal vaccine could protect against 91 percent of targeted bacterial strains

Posted by on November 22, 2017 5:14 pm
Categories: Top News

Up to 91 percent of bacterial strains causing a common type of invasive serogroup B meningococcal disease in children and young adults are likely to be covered by a four-component vaccine called MenB-4C (Bexsero), according to laboratory studies.

Leave a Reply

Your email address will not be published. Required fields are marked *